BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.

🇸🇬Singapore

Country: 🇸🇬Singapore

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

44

HSA:44

Drug Approvals

SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML

Approval Date: Oct 12, 2023

HSA

SPIOLTO® RESPIMAT® RE-USABLE SOLUTION FOR INHALATION 2.5 MICROGRAM / 2.5 MICROGRAM

Approval Date: Feb 25, 2020

HSA

SPIRIVA® RESPIMAT® RE-USABLE SOLUTION FOR INHALATION 2.5 MICROGRAM

Approval Date: Feb 18, 2020

HSA

GLYXAMBI FILM-COATED TABLETS 10 MG/5 MG

Approval Date: Jun 16, 2017

HSA

GLYXAMBI FILM-COATED TABLETS 25 MG/5 MG

Approval Date: Jun 16, 2017

HSA

PRAXBIND SOLUTION FOR INJECTION/INFUSION 50 MG/ML

Approval Date: Aug 31, 2016

HSA

JARDIANCE DUO FILM COATED TABLET 12.5MG/1000MG

Approval Date: Aug 3, 2016

HSA

JARDIANCE DUO FILM COATED TABLET 5MG/500MG

Approval Date: Aug 3, 2016

HSA

JARDIANCE DUO FILM COATED TABLET 12.5MG/850MG

Approval Date: Aug 3, 2016

HSA

JARDIANCE DUO FILM COATED TABLET 12.5MG/500MG

Approval Date: Aug 3, 2016

HSA

Prev
1
2
3
4
5
Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

Privacy Policy
Terms & Conditions

© 2025 MedPath, Inc. All rights reserved.